Skip to content

For in vitro research use only. Not for human or animal consumption.

VaultLabs logo
Retatrutide + Cagrilintide 15mg (RETA/CAG) research vial — reference-grade research material UAEVialTap to zoom
Research PeptidesIn stock

Retatrutide + Cagrilintide 15mg (RETA/CAG)

15 mg blend · Lyophilized

4.7· 16 VaultLabs customer reviews
Third-party testedVaultLabs tested · 99.89%

Price (AED)

AED 649

per vial · AED 43.27 / mg

Listed prices are exclusive of VAT. UAE VAT (5%) is added once at checkout on the post-discount merchandise subtotal, the delivery fee, and any payment fee.

Minimum order AED 150 merchandise, before discount, delivery, and VAT.

Or split into 4 interest-free payments withtamara

24h dispatch

Buy more, save moreUp to 20% off this product

Add 1 more to save 5%

WhatsAppTelegram
Secure checkout
  • tamaraTamara
  • VISAVisa
  • Mastercard
  • PayApple Pay
  • PayGoogle Pay
  • CODCash on delivery

Free UAE delivery unlockedAED 500

  1. Order today

    Pay in AED

  2. Dispatched in 24h

    7 days a week

  3. Delivered

    Next-day option

Third-party testedVaultLabs tested · 99.89%

Every batch is tested by an independent lab before release, then checked on the VaultLabs certificate. The lab report is available on request.

Certificate for this lotVerify lot
  • COA-backed batch
  • Lot-tracked vial
  • Secure checkout
  • Returns policy

Delivery to your emirate

Dispatch: Dispatched within 24 hours, 7 days a week

Arrival: After dispatch: next-day options arrive in 1 UAE business day after dispatch; standard arrives in 4 UAE business days after dispatch.

This amount meets the free-delivery threshold — confirmed after discounts at checkout.

Listed prices are exclusive of VAT. UAE VAT (5%) is added once at checkout on the post-discount merchandise subtotal, the delivery fee, and any payment fee.

View comparison

Volume orders: wholesale access

For in vitro research use only. Not for human or animal consumption. Documentation published when available per batch.

Molecular identity

Molecular weight
4,731 + ~4,409 Da
Chain length
39 + 37 amino acids
Structure
Retatrutide + cagrilintide research blend

Components

Retatrutide (LY3437943, 39 aa, C20 diacid) + cagrilintide (long-acting amylin analog).

Both components are albumin-engineered weekly peptides in the published literature. Envelope follows retatrutide (~6 day t½).

Identity fields above are registry and catalogue descriptions. They are not pharmacokinetic measurements of this lot and are not a substitute for the published certificate.

Certificate of Analysis

Verified COA for this product

Your current batch LOT is loaded automatically. View the published certificate, download a PDF, or verify a different vial below.

View COAScan QR to verify

Verify LOT

Current batch pre-filled — edit to check a different vial.

Full COA page

Technical specifications

Product overview

RETA/CAG is a dual-component lyophilized research blend of retatrutide (12.5 mg) and cagrilintide (2.5 mg) in a 15 mg catalog unit — not a dual-strength GLP-3 RT kit. VaultLabs supplies this retatrutide + cagrilintide blend for comparative in vitro laboratory studies with independent lot tracking from single-sequence GLP-3 RT SKUs. Strictly for qualified analytical research — not for human or animal consumption.

Lyophilized peptide blend · HPLC verification on published COA · VaultLabs code VL-RETA-CAG-15 · Appearance: White to off-white lyophilized blend

Research context

  • 15 mg blend · retatrutide 12.5 mg + cagrilintide 2.5 mg on label
  • Research hub: /research/reta-cag
  • Do not share COAs with GLP-3 RT 10mg or 20mg single-sequence SKUs

Technical specifications

Full product name
Retatrutide + Cagrilintide 15mg (RETA/CAG)
Product category
Research Peptides
Product code
VL-RETA-CAG-15
Strength / amount
15 mg blend
Physical form
Lyophilized
Purity
99.89%
Testing method
HPLC
Laboratory
VaultLabs Laboratory
Test date
2026-07-15
Current lot number
VL-RETACAG-20260801
Manufacturing / packaging date
2026-07-01

Chemical identifiers

Chemical name
Retatrutide + cagrilintide research blend
Synonyms
RETA/CAG, retatrutide 12.5 mg + cagrilintide 2.5 mg
Product code
VL-RETA-CAG-15
Grade
Research grade — for in vitro laboratory research use only
Material class
Lyophilized peptide blend

Current batch documentation

COA available for current shipping lotLOT: VL-RETACAG-20260801
View certificateVerify batch

Storage and handling

2–8 °C · protect from light

Store sealed lyophilized material at 2–8 °C, protected from light and moisture until opened under laboratory conditions.

Shipping information

Supply role
UAE distributor — dispatched from Dubai
Dispatch location
Dubai, United Arab Emirates
Shipping / packaging
Cold-chain aware insulated packaging on UAE dispatch with lot traceability.
Availability
In stock
Dispatch estimate
Dispatched within 24 hours, 7 days a week
VAT
Listed prices are exclusive of VAT. UAE VAT (5%) is added once at checkout on the post-discount merchandise subtotal, the delivery fee, and any payment fee.

Packaging and dispatch

Cold-chain aware insulated packaging on UAE dispatch with lot traceability.

Research-use policy

Products are intended exclusively for in vitro laboratory research, analytical testing, and scientific study. VaultLabs does not provide dosage, administration, study-design, or medical guidance.

Full research-use policy

Frequently asked questions

No. Retatrutide + Cagrilintide 15mg (RETA/CAG) is supplied strictly as a laboratory reference material for in vitro research. It is not for human or animal consumption, and not for medical, personal or diagnostic use. The declaration made at checkout is retained with the order record.

15 mg blend of lyophilized, sealed and lot-numbered. Lyophilized peptide blend · HPLC verification on published COA · VaultLabs code VL-RETA-CAG-15 · Appearance: White to off-white lyophilized blend

2–8 °C · protect from light. Store sealed lyophilized material at 2–8 °C, protected from light and moisture until opened under laboratory conditions.

Yes. Every vial carries a lot number that resolves through batch verification to the certificate published for that batch. A purity figure belongs to the lot it was measured on and should not be generalised across the product line.

The current published lot is VL-RETACAG-20260801, batch B-RETACAG-2026-08. The laboratory named on that certificate is VaultLabs Laboratory. Published purity is 99.89% by HPLC. Janoshik Analytical and METS Lab appear on a batch only when that lot has their report.

Cold-chain aware insulated packaging on UAE dispatch with lot traceability.

No. VaultLabs supplies reference-grade materials and published analytical documentation only. We cannot advise on dosage, administration, or use in humans or animals. Handling and reconstitution references are available in the research library.

Related research materials

VaultLabs customer reviews

Reviews for Retatrutide + Cagrilintide 15mg (RETA/CAG)

All site reviews

Customer feedback comments on packaging, delivery, support, and documentation — not medical outcomes. Reviews are moderated for authenticity and research-use compliance. Tap a review to see who wrote it.

Questions & answers

Questions about Retatrutide + Cagrilintide 15mg (RETA/CAG)

No published questions for this product yet. Ask about documentation, storage, specifications, delivery or wholesale terms and our team will answer here.

Submit feedback

Review Retatrutide + Cagrilintide 15mg (RETA/CAG)

Your review will appear on this product page after moderation. Focus on packaging, delivery, support, or documentation — optional photo of packaging (no product effects).

Third-party testedVaultLabs tested · 99.89%

Tested before release

Each catalogue batch is tested by an independent laboratory before release, then checked again on the VaultLabs certificate. The laboratory report for this lot is available on request, and the laboratory is named on that report.

Lot VL-RETACAG-20260801 · 99.89%

Traceable lot numbersCOA verificationBatch verificationDocumentation availableLab testing standards